D-Ala-Leu integrates a D-amino acid with a hydrophobic L-residue, offering a platform to study stereochemical effects on peptide stability. The sequence reveals altered backbone geometry that impacts folding and enzyme recognition. Researchers use it to evaluate chirality-driven binding properties. Applications span peptide engineering, conformational analysis, and synthetic method testing.
CAT No: R2422
CAS No:67113-60-4
Synonyms/Alias:D-Ala-Leu;67113-60-4;D-alanyl-L-leucine;L-Leucine, D-alanyl-;H-D-ALA-LEU-OH;(S)-2-((R)-2-Aminopropanamido)-4-methylpentanoic acid;(2S)-2-[(2R)-2-aminopropanamido]-4-methylpentanoic acid;D-alanylleucine;d-Alanyl-l-leucin;D-Ala-L-Leu;SCHEMBL7651656;CHEBI:73838;MFCD00066033;AKOS010842261;HY-W212029;BS-24800;CS-0274596;F87608;EN300-7374554;Q27144160;(S)-2-((R)-2-Aminopropanamido)-4-methylpentanoicacid;
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.